Our take
Tyromotion sells a full rehab gym rather than one robot. A clinic can cover hand, arm, balance and gait therapy from one supplier and one software platform.1
Its Lexo gait trainer is built for throughput. Short setup and integrated trunk support let therapists treat many different patients a day.3
Scores by criterion
Each criterion is defined on our methodology page.
Who uses Tyromotion and what it's for
Rehabilitation hospitals and outpatient clinics treating stroke, spinal cord injury and cerebral palsy patients.3
Clinics that want hand, arm, balance and gait devices on one platform.1
History
Alexander Kollreider and David Ram founded Tyromotion in Graz in 2007, starting from a finger-and-hand therapy prototype built for a thesis. Majority owner SHS and the company are preparing a possible sale, and Andreas Mühlenbeck became CEO on November 1, 2026.5,2
Tyromotion GmbH booked EUR15.56 million in revenue for the fiscal year ended March 31, 2025, and expects about EUR25 million and EUR5 million to EUR7 million of EBITDA for 2026. It runs a US subsidiary in Marietta, Georgia.4,5,3
Lexo and the device range
Lexo is an end-effector robotic gait trainer for patients from 15 kg to 180 kg and 100 cm to 200 cm tall, with Pelvis Plus trunk support, active and passive modes and a pediatric kit. It stands 231 cm tall.3
The range also includes Amadeo for fingers and hand, Diego for arm and shoulder, Pablo, Myro, Tymo, Omego Plus, Elvis and the Maya patient management software.3,1
Pricing
Tyromotion quotes devices per clinic, with installation, onboarding, clinical training and maintenance offered as part of its service.1
In 2017 Tyromotion reported an average price of about EUR150,000 per device including software, with 1,500 devices sold to 300 therapy centers.5
Competitive landscape
| Company | Product | Pricing model | Deployment footprint | Where Tyromotion wins or loses |
|---|---|---|---|---|
| Tyromotion | Lexo end-effector gait trainer plus hand, arm and balance devices3 | About EUR150,000 average per device (2017)5 | EUR15.56M revenue in FY to March 20254 | Full device range with fast-setup Lexo gait trainer |
| Hocoma | Lokomat robotic gait trainer and movement therapy devices7 | Lokomat Pro FreeD Kombi about EUR881,292 in 20228 | Definitive debt moratorium to April 9, 20279 | Hocoma wins on Lokomat evidence and installed base. Tyromotion wins on stability and setup speed. |
| Wandercraft | Atalante X and Eve self-balancing exoskeletons18 | Not published18 | Devices in more than 700 rehabilitation centers after buying Ekso19 | Wandercraft wins on hands-free overground walking. Tyromotion wins on clinic throughput. |
| Cyberdyne | Medical HAL wearable robot driven by the wearer's bioelectric signals13 | Not published; mainly rentals and treatment services14 | Approvals or certifications in more than 20 countries20 | Cyberdyne wins on bioelectric HAL control. Tyromotion wins on a broader device range. |
| Lifeward | ReWalk personal exoskeleton and AlterG anti-gravity systems17 | Medicare fee of $91,032 for a personal exoskeleton16 | Individual users through Medicare and insurers; AlterG in more than 4,000 facilities16 | Lifeward wins on personal exoskeletons. Tyromotion wins on clinic-wide therapy systems. |
Limits
A pending sale process could change ownership and strategy.5
The new CEO took over on November 1, 2026.5
Lexo is a stationary end-effector trainer, so overground walking practice needs a separate device.3
What customers say
Where it helps
Clinics building a complete robotic rehab gym get the most from Tyromotion.1
High-volume gait programs that need fast patient changeover benefit from Lexo.3
Where it falls short
Clinics wanting overground exoskeleton walking should look at Wandercraft or Lifeward.
Leadership

Andreas Mühlenbeck
CEOMühlenbeck became CEO on November 1, 2026, after more than 25 years in medical technology.5,2

Alexander Kollreider
Co-founder and CTOKollreider co-founded Tyromotion in Graz and leads its technology.5,2
Sources
- Tyromotion, Homepage, accessed November 9, 2026
- Tyromotion, Team, accessed November 9, 2026
- Tyromotion, Lexo gait trainer, accessed November 9, 2026
- Researchly, Tyromotion GmbH annual accounts, accessed November 9, 2026
- Die Gründer, Tyromotion founders, sale process and new CEO, November 2026, accessed November 9, 2026
- DIH Holding US, Form 10-K for fiscal year ended March 31, 2025, accessed November 9, 2026
- DIH, Hocoma, accessed November 9, 2026
- Springer, Lokomat cost study, accessed November 9, 2026
- Moneyhouse, Hocoma AG, accessed November 9, 2026
- Wandercraft, Atalante X, accessed November 1, 2026
- Wandercraft, Eve personal exoskeleton, accessed November 1, 2026
- Wandercraft, Wandercraft acquires Ekso Bionics, accessed November 1, 2026
- Cyberdyne, Medical HAL lower limb type, accessed November 2, 2026
- Cyberdyne, Financial results briefing for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
- Cyberdyne, Consolidated financial results for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
- Lifeward, Form 10-Q for the quarter ended September 30, 2024, accessed November 1, 2026
- Lifeward, Fourth quarter and full year 2025 financial results, accessed November 1, 2026
- Wandercraft, Homepage, accessed November 2, 2026
- IZON, Wandercraft acquires Ekso Bionics to form major exoskeleton player, accessed November 2, 2026
- Cyberdyne, About Cyberdyne, accessed November 3, 2026


